Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
European Journal of Cancer
Published September 29, 2026
Timing of first-line palliative systemic therapy in metastatic esophagogastric adenocarcinoma: A ...
October 3, 2026
Medspoke
Medspoke
Leukemia
Published October 2, 2026
00:00
--:--
First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade ...
October 3, 2026
Share
First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival.
https://www.medspoke.co/channel_journal?id=794&tap_id=14972
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Diabetes Care
Published October 2, 2026
Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA...
October 3, 2026
Why are you reporting this TALK?